BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Third Wave Technologies, Inc. (TWTI) Prevails in Claim Construction Proceeding


7/25/2007 9:51:01 AM

MADISON, Wis., July 24 /PRNewswire-FirstCall/ -- Third Wave Technologies Inc. today announced that the U.S. District Court for the Western District of Wisconsin earlier today issued a patent claim construction order and opinion, sometimes referred to as a Markman order, in the patent litigation between Third Wave and Digene Corp. In these orders, the court interprets and defines disputed claim terms within a patent at issue.

The court in today's Markman order in the Third Wave-Digene case agreed with each and every of Third Wave's definitions for the disputed patent claim terms. The Markman opinion and order can be found at http://www.twt.com.

"We are pleased with the Markman order issued by the court today," said Kevin T. Conroy, president and chief executive of Third Wave. "We believe the order reinforces the narrow scope of the asserted patent claims and Third Wave's position that we do not infringe. Today's Markman order also strengthens our view that Digene's suit was brought in an attempt to impede competition in the HPV testing market. Third Wave looks forward to proceeding on the merits of the patent case. We also look forward to a February 2008 trial date on our anti-trust claims against Digene based on its anti-competitive behavior."

The company anticipates filing a motion for summary judgment of non- infringement and invalidity in Sept. 2007.

About Third Wave Technologies

Third Wave develops and markets molecular diagnostic reagents for a variety of DNA and RNA analysis applications to meet the needs of our customers. The company offers a number of products based on its Invader(R) chemistry for clinical testing. Third Wave offers in vitro diagnostic kits, and analyte specific, general purpose, and research use only reagents for nucleic acid analysis. For more information about Third Wave and its products, please visit the company's website at http://www.twt.com.

All statements in this news release that are not historical are forward-looking statements within the meaning of the Securities Exchange Act of 1934 as amended. Such forward-looking statements are subject to factors that could cause actual results to differ materially for Third Wave from those projected. Those factors include risks and uncertainties relating to the company's ability to bring new products to market as anticipated, the current regulatory environment in which the company sells its products, the market acceptance of those products, dependence on partners and customers, successful performance under collaborative and commercial agreements, competition, the strength of the Third Wave intellectual property, the intellectual property of others and other risk factors identified in the documents Third Wave has filed, or will file, with the Securities and Exchange Commission. Copies of the Third Wave filings with the SEC may be obtained from the SEC Internet site at http://www.sec.gov. Third Wave expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward- looking statements contained herein to reflect any change in Third Wave's expectations with regard thereto or any change in events, conditions, or circumstances on which any such statements are based. Third Wave Technologies, Invader and the Third Wave logo are trademarks of Third Wave Technologies, Inc.

Contact: Rod Hise The Luminis Group, Ltd. for Third Wave Technologies Inc. 608 807-4607

Third Wave Technologies Inc.

CONTACT: Rod Hise of The Luminis Group, Ltd., +1-608-807-4607, for ThirdWave Technologies Inc.


Read at BioSpace.com


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->